Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug:107:104839.
doi: 10.1016/j.oraloncology.2020.104839. Epub 2020 Jun 4.

Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium

Affiliations
Comment

Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium

Pallvi Kaul et al. Oral Oncol. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declared that there is no conflict of interest.

Comment on

References

    1. Shukla N.K., Deo S.V.S., Garg P.K., Manjunath N.M.L., Bhaskar S., Sreenivas V. Operable Oral Tongue Squamous Cell Cancer: 15 Years Experience at a Tertiary Care Center in North India. Indian J Surg Oncol. 2018;9:15–23. - PMC - PubMed
    1. Day A.T., Sher D.J., Lee R.C., Truelson J.M., Myers L.L., Sumer B.D. Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks. Oral Oncol. 2020;105 - PMC - PubMed
    1. Vermorken J.B., Remenar E., van Herpen C., Gorlia T., Mesia R., Degardin M. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357:1695–1704. - PubMed
    1. Lorch J.H., Goloubeva O., Haddad R.I., Cullen K., Sarlis N., Tishler R. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol. 2011;12:153–159. - PMC - PubMed
    1. Chaves A.L.F., Castro A.F., Marta G.N., Junior G.C., Ferris R.L., Giglio R.E. Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic. Oral Oncol. 2020;107 - PMC - PubMed